Compound ID | 764
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Streptococcus pyogenes, Staphylococcus aureus, and Mycobacterium smegmatis |
| Description: | Natural product from Actinomycete strain; Song Y, Domagala JM, Turner WR, et al. Boxazomycin analogues as new antibacterial agents synthesis and structure-activity relationships. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 116. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1995 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135527050 |
| Citation: | https://doi.org/10.1021/ja00217a043 |